Medications are an essential aspect of health care. The PharmacoEpidemiology & Drug Safety (PharmaSafe) research group covers a multitude of different research activities related to the safety and optimal use of medications, on both the individual and societal level. We are a multidisciplinary team of researchers, with expertise in a wide range of topics, including pharmacoepidemiology and drug safety, pharmaco(epi)genetics, biostatistics, health economics, and pharmacotherapy.
Using epidemiological methods, we address questions of drug safety that are challenging to study in randomized controlled trials (RCTs). Our work includes monitoring of drug utilization in pregnancy, examination of perceptions toward medications, methodology and health economic research, and analysis of medication safety on patient outcomes, including genetic and epigenetic contributions.
News
-
February Publications from PharmaSafe Mar. 7, 2024 1:41 PM
In February 2024, PharmaSafe Research Group published four new publications, demonstrating our involvement in research and collaboration. Read on for a summary of our latest publications:
-
AstraZeneca's Real World Evidence (RWE) Day: Connecting Academia and Industry Mar. 5, 2024 5:08 PM
AstraZeneca's RWE department hosted PharmaSafe research group for a seminar on Wednesday, February 28th.
-
Recent Research Insights: January Publications from PharmaSafe Research Group Feb. 23, 2024 10:47 AM
PharmaSafe research group kicks off 2024 with 5 new publications! In January, our group made significant contributions to healthcare and medical science. Here's a summary of our latest publications:
-
Rajesh Shigdel joins PharmaSafe! Feb. 16, 2024 5:02 PM
We are excited to introduce Rajesh Shigdel, a new researcher, to PharmaSafe! Read on to learn more about his experience in public health research.
-
Emma van Wijk visits PharmaSafe Feb. 14, 2024 10:15 AM
Please join us in welcoming iAPOGEE fellow Emma van Wijk to Oslo! Read on to learn more about her background and research interests.